Blog
The plan includes adding a wholesale tax to marijuana sales to generate $470 million. The post Michigan governor’s road tax plan has cannabis industry on edge appeared first on Green Market Report.
Trump’s choice for DEA administrator has publicly opposed marijuana legalization. The post Trump taps anti-cannabis hardliner for top DEA job appeared first on Green Market Report.
A district court judge has blocked the city of Colorado Springs from asking voters to repeal recreational marijuana sales they approved in November. Colorado Springs can’t sidestep voters on recreational marijuana, judge rules is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Michigan’s governor is suggesting taxing adult-use cannabis an additional 32% to fund a $3 billion infrastructure plan. Michigan governor floats extra 32% adult-use cannabis tax to fund roads is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex. Pharma giant Jazz dismisses final patent claim involving cannabinoid epilepsy drug is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Cannabis industry insiders are set to converge this March 19th-20th for the 2025 Hall of Flowers industry-only trade show. The iconic event brings all the movers and shakers of the cannabis industry together in one place. The post Ventura Hall of Flowers is March 19–20—is your business ready? appeared first on Leafly.
The Canadian cannabis producer missed revenue expectations but posted stronger margins as international sales surge. The post Organigram posts mixed results but touts international growth after Motif deal appeared first on Green Market Report.
Glass House attributed the solid results to cost cutting and lower production costs, along with increased same-store sales. The post Glass House raises guidance for its fourth quarter and 2024 results appeared first on Green Market Report.
Cybin pushes forward with Phase 3 depression trials after narrowing its loss, while securing a $100M funding program. The post Cybin sees third-quarter loss on R&D costs, advances clinical programs appeared first on Green Market Report.
Many businesses are grappling with declining wholesale prices, compliance costs and limited access to banking. The post Businesses in receivership flood the market amid cannabis industry challenges appeared first on Green Market Report.